To better understand the role of the SETD2 in tumor metabolism in RCC progression, we systematically investigated the function of SETD2 in PKD-ccRCC transition based on comprehensive analyses of transcriptomics, proteomics, lipidomics and metabolomics. This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.